TNDM Q2 2021 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$2B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$172M+57.6% YoY

Gross Profit

$92M53.7% margin

Operating Income

$5M3.2% margin

Net Income

$4M2.3% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+22.1%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$18M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$795M

Total Liabilities

$449M

Stockholders' Equity

$346M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$172M	$109M	+57.6%
Gross Profit	$92M	$54M	+70.0%
Operating Income	$5M	-$12M	+145.1%
Net Income	$4M	-$27M	+114.8%

Geographic Segments

UNITED STATES

$128M74%

Non-US

$45M26%